Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCE
3701
DELISTED
Claymore/Robb CEF GS Connect ETN
GCE
| $1.33M | ﹤0.01% |
115,294
| – | – |
|
3702
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
| $1.33M | ﹤0.01% |
25,452
+13,070
| +106% | +$672K |
|
3703
InMode
INMD
$869M
| $1.33M | ﹤0.01% |
93,614
+61,540
| +192% | +$823K |
|
3704
Surgery Partners
SGRY
$1.95B
| $1.32M | ﹤0.01% |
114,124
-420,959
| -79% | -$4.61M |
|
3705
Tilly's
TLYS
$126M
| $1.32M | ﹤0.01% |
232,890
+15,308
| +7% | +$78.9K |
|
3706
Global Partners
GLP
$1.65B
| $1.31M | ﹤0.01% |
133,974
+59,597
| +80% | +$613K |
|
3707
BJ's Restaurants
BJRI
$1.49B
| $1.31M | ﹤0.01% |
62,485
-60,989
| -49% | -$1.21M |
|
3708
ATN International
ATNI
$471M
| $1.31M | ﹤0.01% |
21,596
-30,657
| -59% | -$1.84M |
|
3709
Compass Diversified
CODI
$810M
| $1.3M | ﹤0.01% |
75,498
-7,488
| -9% | -$128K |
|
|
PR
3710
Permian Resources
PR
$17B
| $1.3M | ﹤0.01% |
1,459,844
-2,865,261
| -66% | -$2.52M |
|
3711
Clarivate
CLVT
$1.18B
| $1.3M | ﹤0.01% |
58,154
+44,096
| +314% | +$996K |
|
3712
LeMaitre Vascular
LMAT
$1.85B
| $1.3M | ﹤0.01% |
49,154
-28,237
| -36% | -$738K |
|
|
BRSP
3713
BrightSpire Capital
BRSP
$639M
| $1.29M | ﹤0.01% |
184,047
-35,127
| -16% | -$180K |
|
3714
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.36B
| $1.29M | ﹤0.01% |
16,867
| – | – |
|
3715
CALL
Medifast
MED
$136M
| $1.29M | ﹤0.01% |
+9,300
| New | +$854K |
|
|
CATC
3716
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.29M | ﹤0.01% |
+21,771
| New | +$1.15M |
|
3717
PDF Solutions
PDFS
$1.92B
| $1.29M | ﹤0.01% |
65,867
-96,410
| -59% | -$1.57M |
|
3718
CALL
Zoetis
ZTS
$32.4B
| $1.29M | ﹤0.01% |
9,400
+3,100
| +49% | +$405K |
|
|
3719
PUT
Zoetis
ZTS
$32.4B
| $1.29M | ﹤0.01% |
+9,400
| New | +$1.23M |
|
3720
Agilysys
AGYS
$3.03B
| $1.28M | ﹤0.01% |
71,592
-62,776
| -47% | -$1.18M |
|
3721
NextCure
NXTC
$22.7M
| $1.28M | ﹤0.01% |
4,985
+42
| +0.8% | +$16K |
|
|
CBD
3722
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $1.28M | ﹤0.01% |
+97,987
| New | +$1.18M |
|
3723
Vermilion Energy
VET
$1.68B
| $1.28M | ﹤0.01% |
286,927
-49,145
| -15% | -$231K |
|
3724
Otter Tail
OTTR
$3.91B
| $1.28M | ﹤0.01% |
32,947
-11,146
| -25% | -$469K |
|
3725
PUT
Bilibili
BILI
$7.81B
| $1.27M | ﹤0.01% |
+27,500
| New | +$893K |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.